[HTML][HTML] Salivary microbiome with gastroesophageal reflux disease and treatment

N Kawar, SG Park, JL Schwartz, N Callahan, A Obrez… - Scientific reports, 2021 - nature.com
The effect of oral microbial composition on periodontal health and on systemic health has
been, and is being established. The oral microbiome, in turn, can be altered by local and …

[HTML][HTML] Proton pump inhibitors and risk of chronic kidney disease: evidence from observational studies

CC Wu, MH Liao, WM Kung, YC Wang - Journal of Clinical Medicine, 2023 - mdpi.com
Previous epidemiological studies have raised the concern that the use of proton pump
inhibitors (PPIs) is associated with an increased risk of kidney diseases. To date, no …

[HTML][HTML] Evidence of drug–nutrient interactions with chronic use of commonly prescribed medications: An update

ES Mohn, HJ Kern, E Saltzman, SH Mitmesser… - Pharmaceutics, 2018 - mdpi.com
The long-term use of prescription and over-the-counter drugs can induce subclinical and
clinically relevant micronutrient deficiencies, which may develop gradually over months or …

Identification of quinoline-chalcone hybrids as potential antiulcer agents

KV Sashidhara, SR Avula, V Mishra, GR Palnati… - European journal of …, 2015 - Elsevier
Antiulcer activity of novel quinoline-chalcone hybrids (13–37) was investigated. Among
them, eight compounds (14, 16, 17, 23, 29, 31, 32 and 35) were found to be active in various …

Use of proton pump inhibitors and risk of iron deficiency: a population‐based case–control study

A Tran‐Duy, NJ Connell, FH Vanmolkot… - Journal of internal …, 2019 - Wiley Online Library
Background Hypochlorhydric states are an important cause of iron deficiency (ID).
Nevertheless, the association between therapy with proton pump inhibitors (PPI s) and ID …

Are proton pump inhibitors really so dangerous?

V Savarino, P Dulbecco, E Savarino - Digestive and Liver Disease, 2016 - Elsevier
For decades, millions of patients with acid-related disorders have had their acid inhibited
effectively and safely first with H2-receptor antagonists (H2RAs) and then with proton pump …

[HTML][HTML] Recent developments in metallic degradable micromotors for biomedical and environmental remediation applications

S Dutta, S Noh, RS Gual, X Chen, S Pané, BJ Nelson… - Nano-Micro Letters, 2024 - Springer
Synthetic micromotor has gained substantial attention in biomedicine and environmental
remediation. Metal-based degradable micromotor composed of magnesium (Mg), zinc (Zn) …

Proton pump inhibitor–associated hypomagnesemia: what do FDA data tell us?

CP Luk, R Parsons, YP Lee… - Annals of …, 2013 - journals.sagepub.com
BACKGROUND: Proton pump inhibitors (PPIs) are a class of medications indicated for the
treatment of gastric acid–related diseases. Hypomagnesemia is a rare but serious adverse …

[HTML][HTML] Phenolic acids-rich fraction from Ficus drupacea leaves for the prevention and treatment of ethanol-induced gastric mucosal injury in rats

SM Bakry, AFA Naser, SIE Negoumy… - …, 2023 - Springer
Bioactivity-guided fractionation of F. drupacea Thunb. extract revealed that the water fraction
(FDWF) increased pH of the artificial gastric juice from 1.2 to 5.67±0.015. The …

Oral microbiome alterations of healthy volunteers with proton pump inhibitor

T Mishiro, K Oka, Y Kuroki, M Takahashi… - Journal of …, 2018 - Wiley Online Library
Abstract Background and Aim Acid suppressive agents including proton pump inhibitors
(PPIs) are used as first‐line treatment for various acid‐related gastrointestinal disorders …